查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1944904

无结组织缝合器材市场：依产品类型、可吸收性、给药方式、聚合物结构、应用和最终用户划分，全球预测，2026-2032年

Knotless Tissue-Closure Device Market by Product Type, Absorbability, Mode Of Delivery, Polymer Structure, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年无结组织闭合装置市值为 3.6612 亿美元，预计到 2026 年将成长至 3.9862 亿美元，预计到 2032 年将达到 5.9584 亿美元，复合年增长率为 7.20%。

关键市场统计数据
基准年 2025 3.6612亿美元
预计年份：2026年 3.9862亿美元
预测年份 2032 5.9584亿美元
复合年增长率 (%) 7.20%

无结组织缝合装置概述：检验临床效用、手术效率、推广驱动因素、法规环境及其对当代外科实践的影响

无结组织闭合装置旨在透过材料科学、手术效率和手术系统集成，简化缝合、缩短手术时间并提高伤口完整性。这些装置结合了工程聚合物结构和可控输送机制，无需手动打结即可实现牢固的组织闭合，从而取代或补充传统打结方法。这为临床医生提供了稳定的张力控制，可能减少结节部位的异物感，并降低与结节断裂和挤出相关的併发症发生率。

临床创新、手术自动化和微创手术的发展趋势如何重新定义设备需求并重塑各专科的手术标准

无结组织缝合器材领域正经历变革性的转变，这主要得益于外科技术、器材工程和医疗保健系统优先事项的整合。聚合物化学的创新催生了具有可预测拉伸强度衰减曲线的可吸收材料。这些材料与编织和单丝等先进的聚合物结构相结合，为临床医生提供了不同组织类型和癒合时间的客製化选择。同时，微创手术和机器人辅助平台的持续进步，要求器械的输送机制能够与有限的网路基地台和可弯曲的手术器械无缝衔接，从而加速了对单切口和多孔缝合器械的需求。

评估2025年美国关税对供应链、零件采购、监管完整性和全球筹资策略的连锁影响

美国将于2025年实施的关税政策，为依赖国际供应链取得关键医疗设备组件和成品的製造商、经销商和医疗保健系统带来了新的复杂性。关税造成的成本压力迫使企业重新评估其筹资策略，优先考虑本地供应商并实现采购管道多元化，以降低其受关税波动的影响。因此，各机构正在权衡关税带来的即时成本影响与长期资本投资之间的关係，例如转移关键生产流程、寻找合格的替代材料以及重新设计包装和物流，以最大限度地降低课税进口阈值。

针对特定细分市场的情报，揭示应用、最终用户、吸收、给药途径和聚合物结构等方面的动态变化，从而指导产品开发和定位。

透过对无结组织缝合材料市场进行应用、终端用户、吸收性、给药方式和聚合物结构等方面的分析，可以发现针对临床需求和医疗环境量身定制的差异化创新机会和商业化路径。在心血管外科、一般外科、妇科、眼科、整形外科和整形外科等应用领域中，每种应用都有独特的机械性能和操作要求。心血管外科手术需要高拉伸可靠性和可预测的长期性能，以用于瓣膜修復和血管吻合。同时，一般外科手术，例如腹壁缝合、胃肠道吻合和疝气修补，优先考虑的是可操作性，以便快速进行腹腔内操作。妇科手术，包括剖腹产、子宫悬吊术和阴道修补术，需要使用能够最大限度减少组织摩擦并降低敏感解剖区域刺激的材料和给药方式。眼科应用，例如白内障手术和角膜缝合，则需要超薄的缝合线和最小的组织反应。整形外科应用，包括关节镜。另一方面，整形外科应用，如美容和重组手术，则需要在美观效果和最大限度减少疤痕之间取得平衡。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和需求动态将驱动产品的采用、报销和分销策略。

区域趋势将在美洲、欧洲、中东和非洲以及亚太地区无结组织缝合器械的普及曲线、支付方预期和分销模式的形成中发挥关键作用。在美洲，整合的医院系统和以价值为导向的采购模式正在推动对能够实现稳定临床疗效和精简供应物流的器械的需求。主要都会区中的早期采用中心往往能够促进区域医疗机构的更广泛采用，而奖励效率的报销环境则加速了临床医生对该器械的接受度。

成熟製造商、新兴创新者、契约製造製造商和临床合作伙伴之间的竞争与合作模式正在影响市场进入策略。

无结组织缝合器材的竞争格局呈现出成熟外科器材製造商、专业创新企业、契约製造和临床伙伴关係之间错综复杂的互动关係。成熟的器械製造商通常利用其广泛的销售管道、与外科医生的现有关係以及丰富的监管经验来加速产品推广，而规模小规模、技术驱动型的公司则往往透过利基材料科学的进步或创新的给药机制来脱颖而出。对于缺乏垂直整合製造能力的新兴企业而言，契约製造製造商和工程服务供应商在快速原型製作、规模化生产和品质系统实施方面发挥着至关重要的作用。

为行业领导者提供切实可行的建议，以加速产品应用、降低商业化风险并优化生产和临床证据策略。

致力于加速无结组织缝合器材推广应用并降低其商业化风险的产业领导者，应采取一系列协调一致的措施，涵盖临床数据、生产策略和商业性执行。首先，应优先产生以可重复性终点为重点的、对外科医生和采购团队有意义的比较性临床证据（例如，生理负荷下的缝合完整性、再次手术率和手术效率指标）。在商业推广初期就纳入前瞻性、真实世界证据的收集，可以加快证据生成速度，并有助于将其纳入采购讨论。

为了确保分析的严谨性，我们采用透明的调查方法，结合了临床访谈、设备工程评估和二手文献综合。

为确保分析的严谨性和实际应用价值，本分析采用混合研究方法，结合了质性访谈、器材工程评估和系统性的文献综述。主要研究包括对循环系统、一般外科、妇科、眼科、整形外科和整形外科的临床医生进行结构化访谈，以及与供应链负责人、监管专家和器械工程师进行对话，以了解现场操作的限制和技术重点。这些访谈有助于提出假设，突出关键应用案例的差异，并检验无结缝合技术的实际性能预期。

本文回顾了相关人员在不断发展的无结扎组织闭合装置领域中面临的策略意义和未来前景。

无结扎组织闭合装置的发展轨迹正受到聚合物科学技术的进步、外科手术技术的不断发展以及采购预期变化的影响，后者更加重视可验证的临床价值和价值链的稳健性。希望掌握这些趋势的相关人员需要以整体观点看待产品开发和商业化，将临床证据、生产柔软性和针对性培训路径整合起来。成功的参与企业是那些能够根据特定手术需求（例如高次数的整形外科修復、精细的眼部闭合或高通量普通外科手术应用）定制装置性能，同时确保与现有器械和临床工作流程兼容的参与者。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 无结组织缝合器材市场（依产品类型划分）

  • 无结倒刺缝合线
    • 单丝
    • 编织
  • 无结缝合锚
    • 软组织锚定
    • 骨锚
  • 无结闭合系统
    • 皮肤闭合系统
    • 筋膜闭合系统
    • 血管闭合系统
  • 无结网状紧固装置
  • 辅助张紧和固定附件

第九章 依吸收率分類的无结组织缝合器材市场

  • 吸收性
    • Poliglecaprone
    • 氧环己酮聚合体
    • Polyglactin
    • 聚乙醇酸
  • 不可吸收
    • 尼龙
    • 聚酯纤维
    • 聚丙烯

10. 依给药途径分類的无结组织闭合装置市场

  • 腹腔镜
    • 多埠
    • 单切口
  • 开放性手术
  • 机器人辅助

11. 依聚合物结构分類的无结组织缝合器材市场

  • 编织
    • 涂层
    • 未涂层
  • 单丝
    • 涂层
    • 未涂层

第十二章 无结组织闭合装置市场（依应用划分）

  • 心血管系统
    • 阀门维修
    • 血管吻合术
  • 一般外科
    • 腹壁闭合
    • 胃肠吻合术
    • 疝气修补术
  • 妇科
    • 剖腹产
    • 子宫固定术
    • 阴道修復
  • 眼科
    • 白内障手术
    • 角膜缝合
  • 整形外科
    • 关节镜缝合
    • 韧带修復
    • 肌腱修復
  • 整形外科
    • 整形手术
    • 重组手术

第十三章 无结组织缝合器材市场（依最终用户划分）

  • 门诊手术中心
    • 医院附属机构
    • 独立的
  • 诊所
    • 医院附设诊所
    • 独立诊所
  • 医院
    • 政府
    • 私人的
  • 专业中心
    • 眼科专科中心
    • 整形外科专科中心

第十四章 无结组织缝合器材市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 无结组织闭合器械市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国无结组织缝合器材市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

17. 美国无结组织缝合器材市场

第十八章：中国无结组织缝合器材市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Angelantoni Life Science Srl
  • Angiotech Pharmaceuticals, Inc.
  • Arctiko A/S
  • Aucma Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Blue Star Limited
  • ConMed Corporation
  • Dometic Group AB
  • Evermed SRL
  • Felix Storch, Inc.
  • Fiocchetti Srl
  • Godrej & Boyce Manufacturing Co. Ltd.
  • Johnson & Johnson
  • Labcold Ltd.
  • LEC Medical
  • Medtronic plc
  • Migali Scientific
  • Smith & Nephew plc
  • So-Low Environmental Equipment Co., Inc.
  • Standex International Corporation
  • Stryker Corporation
  • Teleflex Incorporated
  • Vestfrost
  • Zhongke Meiling Cryogenics Company Limited
Product Code: MRR-F847BD9C749D

The Knotless Tissue-Closure Device Market was valued at USD 366.12 million in 2025 and is projected to grow to USD 398.62 million in 2026, with a CAGR of 7.20%, reaching USD 595.84 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 366.12 million
Estimated Year [2026] USD 398.62 million
Forecast Year [2032] USD 595.84 million
CAGR (%) 7.20%

A concise orientation to knotless tissue-closure devices, examining clinical utility, procedural efficiency, adoption drivers, regulatory context, and implications for surgical practice today

Knotless tissue-closure devices represent a convergence of materials science, procedural ergonomics, and surgical system integration designed to simplify suturing, reduce operative time, and improve wound integrity. These devices replace or augment traditional knotted sutures by combining engineered polymer structures and controlled delivery mechanisms to create secure tissue apposition without manual knot tying. As a result, clinicians gain consistent tension control, reduced foreign-body bulk at knot sites, and the potential to lower complication rates associated with knot failure or prominence.

Clinically, the advantages extend across specialties where precise tissue approximation is essential, and where operating room efficiency or minimally invasive access constrains manual knotting. From an innovation standpoint, the device category has matured from simple knotless anchors to integrated systems that integrate absorbability profiles, polymer geometries, and delivery modalities aligned with laparoscopic and robotic workflows. Consequently, purchasers and clinical leaders are increasingly evaluating these devices not only on immediate procedural outcomes but on downstream effects such as ease of training, inventory rationalization, and the ability to standardize suturing technique across varied user skill levels.

Transitioning from descriptive characteristics to practical implications, stakeholders should consider how knotless technologies fit within broader clinical pathways. Adoption decisions hinge on demonstrated reproducibility in closure strength, compatibility with existing instrumentation, and robust clinician education programs. Furthermore, regulatory clearance patterns and reimbursement narratives influence procurement timelines, making early engagement with clinical champions and supply chain teams essential for smooth introduction into high-volume procedural areas.

How clinical innovation, surgical automation, and minimally invasive trends are realigning device requirements and reshaping procedural standards across specialties

The landscape for knotless tissue-closure devices is undergoing transformative shifts driven by convergence across surgical technique, device engineering, and health system priorities. Innovations in polymer chemistry have enabled absorbable materials that deliver predictable tensile decay profiles, which, when paired with refined polymer structures such as braided or monofilament designs, provide clinicians with choices tailored to tissue type and healing timelines. At the same time, the relentless advance of minimally invasive surgery and robotic-assisted platforms demands delivery mechanisms that integrate seamlessly with constrained access points and articulated instruments, which in turn accelerates demand for single-incision and multiport compatible assemblies.

From a procedural perspective, the pressure to reduce operative time and standardize outcomes is prompting clinicians to prefer solutions that reduce variability in suturing technique. This clinical imperative has fostered collaborations between device designers and surgical educators to embed knotless suturing into training curricula and simulation-based credentialing programs. Moreover, postoperative expectations from payors and patients-driven by quality metrics and shorter hospital stays-are steering device development toward technologies that demonstrably lower complication risks and enable consistent wound healing.

In parallel, supply chain resiliency and cost transparency are reshaping procurement behavior. Hospitals and specialty centers are emphasizing devices with clear lifecycle documentation, vendor-managed inventory options, and demonstrable sterilization and packaging efficiencies. Taken together, these shifts create opportunities for suppliers who can align material science, delivery ergonomics, and commercial models to the operational realities of modern surgical environments, while simultaneously addressing clinician preference and patient-centered outcomes.

Assessing the cascading effects of United States tariffs in 2025 on supply chains, component sourcing, regulatory alignment, and global procurement strategies

The introduction of United States tariffs in 2025 has introduced a new layer of complexity for manufacturers, distributors, and health systems that rely on transnational supply chains for critical device components and finished goods. Tariff-driven cost pressures have prompted firms to reassess sourcing strategies, prioritizing nearshore suppliers and diversified procurement channels to mitigate exposure to variable duties. Consequently, organizations are balancing the immediate cost implications of tariffs with longer-term capital investments to relocate critical manufacturing steps, qualify alternative materials, or redesign packaging and logistics to minimize taxable import thresholds.

Beyond cost, the tariff environment has ripple effects on production planning and inventory management. Manufacturers are increasingly adopting a dual approach: accelerating bilateral supplier qualification while implementing strategic buffer stocks for key components sensitive to tariff volatility. This strategy reduces production disruptions but also places a premium on working capital. Simultaneously, regulatory and quality teams must ensure that substitutions in suppliers or resins do not compromise device integrity or compliance with submission dossiers, which requires structured change control and supplemental testing.

International procurement and contracting teams have responded by renegotiating long-term agreements and exploring bonded logistics and free-trade zone opportunities to reduce customs exposure. For clinicians and hospital procurement leaders, the tariffs translate into a renewed emphasis on total cost of ownership that includes logistics duty, compliance risk, and the potential need for alternative product options. In sum, the tariff environment of 2025 is accelerating a strategic pivot toward supply-chain flexibility, localized manufacturing capabilities, and stronger cross-functional governance between sourcing, regulatory, and clinical teams.

Segment-focused intelligence revealing application, end-user, absorbability, delivery mode, and polymer structure dynamics that inform product development and positioning

Disaggregating the knotless tissue-closure landscape according to application, end-user, absorbability, mode of delivery, and polymer structure reveals differentiated innovation opportunities and commercialization pathways that vary by clinical need and care setting. By application, specialties such as cardiovascular, general surgery, gynecologic, ophthalmic, orthopedic, and plastic surgery each pose unique mechanical and handling requirements. Within cardiovascular procedures, valve repair and vascular anastomosis demand high tensile reliability and predictable long-term performance, whereas general surgery tasks like abdominal wall closure, gastrointestinal anastomosis, and hernia repair prioritize handling characteristics that support rapid intra-abdominal maneuvers. Gynecologic applications, including cesarean section, uterine suspension, and vaginal repair, require materials and delivery modalities that minimize tissue drag and reduce irritation in sensitive anatomic sites. Ophthalmic uses such as cataract surgery and corneal suturing call for ultra-fine profiles and minimal tissue reaction. Orthopedic applications covering arthroscopic closure, ligament repair, and tendon repair typically need robust knotless fixation and secure anchoring under cyclical loading, while plastic surgery applications for cosmetic and reconstructive surgery balance aesthetic outcomes with scar minimization.

Considering end users, adoption dynamics differ between ambulatory surgical centers, clinics, hospitals, and specialty centers. Ambulatory surgical centers, whether hospital affiliated or standalone, often prioritize devices that shorten turnover times and reduce inventory complexity. Clinics, including both hospital-affiliated clinics and independent clinics, place a premium on ease of use and disposability for staff with variable suturing experience. Hospitals, whether government-funded or private, emphasize procurement consistency, demonstrable clinical value, and integration into broader formularies. Specialty centers focused on ophthalmic or orthopedic care seek devices that address very specific procedural workflows and align with high-volume practice patterns.

Material selection and absorbability further stratify product fit. Absorbable options such as poliglecaprone, polydioxanone, polyglactin, and polyglycolic acid offer tailored degradation profiles for tissues that heal predictably, whereas nonabsorbable choices like nylon, polyester, and polypropylene provide long-term structural support where permanent reinforcement is required. Mode of delivery-laparoscopic, open, and robotic assisted-dictates device ergonomics and compatibility, with laparoscopic approaches differentiating between multiport and single incision systems and robotic-assisted workflows often requiring instruments compatible with specific platforms. Finally, polymer structure-braided or monofilament, each with coated or uncoated variants-affects handling, knotless anchoring characteristics, and tissue interaction. Understanding how these segmentation vectors intersect is critical for product designers aiming to match clinical performance with operational and economic realities across diverse care settings.

Regional dynamics and demand signals across the Americas, Europe Middle East and Africa, and Asia-Pacific that drive adoption, reimbursement, and distribution strategies

Regional dynamics play a pivotal role in shaping adoption curves, payer expectations, and distribution models for knotless tissue-closure devices across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, consolidated hospital systems and a focus on value-based procurement drive demand for devices that demonstrate consistent clinical outcomes and streamlined supply logistics. Early adopters in major urban centers often catalyze diffusion into community facilities, and reimbursement environments that reward efficiency can accelerate clinician uptake.

In Europe, Middle East & Africa, regulatory harmonization, variation in public procurement frameworks, and differing hospital funding approaches lead to a mosaic of adoption scenarios. Northern and Western European markets typically emphasize evidence generation and cost-effectiveness analyses, while markets in the Middle East and Africa show heterogeneity driven by infrastructure investments and regional centers of excellence. Across these geographies, distribution partnerships and local regulatory expertise can determine market entry speed and commercial traction.

The Asia-Pacific region presents opportunities driven by high procedural volumes, investments in minimally invasive surgery, and growing domestic manufacturing capabilities. However, fragmented reimbursement landscapes and procurement priorities that favor cost containment necessitate targeted value propositions that emphasize durability, ease of training, and supply chain assurances. Across all regions, successful commercialization depends on aligning clinical evidence strategies with regional regulatory expectations, leveraging local clinical champions, and designing distribution frameworks that reflect the operational nuances of each geography.

Competitive and collaboration patterns among established manufacturers, emerging innovators, contract manufacturers, and clinical partners informing go-to-market tactics

The competitive landscape for knotless tissue-closure devices is characterized by an interplay of established surgical manufacturers, specialized innovators, contract manufacturers, and collaborative clinical partnerships. Incumbent device manufacturers typically leverage broad commercial channels, existing surgeon relationships, and deep regulatory experience to accelerate adoption, whereas smaller technology-focused firms often differentiate through niche material science advancements or novel delivery mechanisms. Contract manufacturers and engineering service providers play an important role in enabling rapid prototyping, scale-up, and quality systems implementation for emerging firms that lack vertically integrated production.

Clinical partnerships are increasingly central to product validation and market acceptance. Strategic alliances between device developers and key opinion leaders in cardiovascular, general surgery, gynecology, ophthalmology, orthopedics, and plastic surgery enable iterative design improvements and create the clinical evidence base necessary for hospital formularies and purchasing committees. Concurrently, collaborative models that include shared-savings or gain-sharing agreements have emerged as alternatives to traditional purchasing, aligning manufacturer incentives with health system priorities around efficiency and outcomes.

Finally, competitive advantage is often determined by nonclinical capabilities such as supply chain robustness, regulatory agility, and the ability to provide comprehensive training and post-market surveillance. Companies that can demonstrate consistent quality, rapid response to field feedback, and structured clinician education are best positioned to capture traction in procedural areas where reproducibility and reliability are paramount.

Practical and actionable recommendations for industry leaders to accelerate adoption, de-risk commercialization, and optimize manufacturing and clinical evidence strategies

Industry leaders seeking to accelerate adoption and de-risk commercialization of knotless tissue-closure devices should pursue a coordinated set of actions spanning clinical data, manufacturing strategy, and commercial execution. First, prioritize the generation of comparative clinical evidence that focuses on reproducible endpoints meaningful to surgeons and procurement teams-such as closure integrity under physiologic loading, incidence of reintervention, and measures of procedural efficiency. Embedding prospective real-world evidence collection into early commercial rollouts can shorten the evidentiary timeline and support inclusion in procurement discussions.

Second, invest in supply chain resilience by qualifying multiple suppliers for critical polymers and components, exploring nearshore manufacturing alternatives, and implementing robust change-control processes to expedite regulatory notifications if materials or processes change. These steps reduce exposure to external shocks and support predictable fulfillment for high-volume centers. Third, design clinician training and onboarding programs tailored to each end-user environment, from ambulatory surgical centers to high-acuity hospitals and specialty clinics. Simulation-based training, proctoring for initial cases, and clear competency benchmarks will reduce variability in technique and support broader adoption.

Finally, align commercial models to reflect institutional priorities by offering flexible contracting, outcome-based pilots, and integrated inventory solutions. Engage early with reimbursement specialists and hospital value-analysis committees to articulate total cost implications, and consider strategic partnerships for clinical research, distribution, and service delivery to accelerate market penetration while preserving quality and compliance.

Transparent research methodology blending primary clinical interviews, device engineering assessments, and secondary literature synthesis to ensure analytical rigor

This analysis is founded on a mixed-methods research approach that blends primary qualitative interviews, device engineering assessments, and systematic secondary literature review to ensure analytical rigor and practical relevance. Primary research included structured interviews with clinicians across cardiovascular, general surgery, gynecology, ophthalmology, orthopedics, and plastic surgery, as well as dialogues with supply chain leaders, regulatory specialists, and device engineers to capture frontline operational constraints and technical priorities. These interviews informed hypothesis framing, highlighted critical use-case differentiation, and validated practical performance expectations for knotless closure technologies.

Engineering assessments focused on material selection, polymer architecture, and delivery-device mechanics, employing bench testing protocols to evaluate handling, tensile performance, and cyclic loading characteristics relevant to diverse anatomic sites. Where applicable, design verification data and peer-reviewed clinical outcomes were synthesized to contextualize device performance relative to procedural demands. Secondary research involved a comprehensive review of clinical guidelines, regulatory pathways, technical white papers, and publicly available safety communications to triangulate evidence and identify potential regulatory or reimbursement implications.

Data integrity was preserved through cross-validation across multiple sources and by documenting methodological assumptions and limitations. Where gaps existed, sensitivity analyses and expert elicitation provided qualitative triangulation. This structured approach supports actionable insights while maintaining transparency about evidence strengths and areas requiring further primary data collection during post-market surveillance or clinical studies.

Concluding synthesis of strategic implications and forward-looking considerations for stakeholders navigating the evolving knotless tissue-closure device landscape

The trajectory for knotless tissue-closure devices is shaped by technical refinements in polymer science, evolving surgical modalities, and shifting procurement expectations that prioritize demonstrable clinical value and supply-chain robustness. Stakeholders seeking to capitalize on these trends must approach product development and commercialization with a holistic lens that integrates clinical evidence, manufacturing flexibility, and targeted training pathways. Successful entrants will be those who align device performance to specific procedural needs-whether that be high-cycle orthopedic repairs, delicate ophthalmic closures, or high-throughput general surgery applications-while ensuring compatibility with existing instrumentation and clinical workflows.

Looking ahead, the most impactful innovations will likely arise at the intersection of material optimization, delivery ergonomics, and integrated clinician education. Coupled with adaptive commercial strategies that reflect regional regulatory and procurement nuances, these advances can facilitate broader adoption and improved patient outcomes. Ultimately, the landscape will favor organizations that commit to rigorous evidence generation, resilient supply chains, and sustained clinical engagement to translate device capabilities into real-world clinical benefit.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Knotless Tissue-Closure Device Market, by Product Type

  • 8.1. Knotless Barbed Sutures
    • 8.1.1. Monofilament
    • 8.1.2. Braided
  • 8.2. Knotless Suture Anchors
    • 8.2.1. Soft Tissue Anchors
    • 8.2.2. Bone Anchors
  • 8.3. Knotless Closure Systems
    • 8.3.1. Skin Closure Systems
    • 8.3.2. Fascial Closure Systems
    • 8.3.3. Vascular Closure Systems
  • 8.4. Knotless Mesh Fixation Devices
  • 8.5. Adjunct Tensioning and Fixation Accessories

9. Knotless Tissue-Closure Device Market, by Absorbability

  • 9.1. Absorbable
    • 9.1.1. Poliglecaprone
    • 9.1.2. Polydioxanone
    • 9.1.3. Polyglactin
    • 9.1.4. Polyglycolic Acid
  • 9.2. Nonabsorbable
    • 9.2.1. Nylon
    • 9.2.2. Polyester
    • 9.2.3. Polypropylene

10. Knotless Tissue-Closure Device Market, by Mode Of Delivery

  • 10.1. Laparoscopic
    • 10.1.1. Multiport
    • 10.1.2. Single Incision
  • 10.2. Open
  • 10.3. Robotic Assisted

11. Knotless Tissue-Closure Device Market, by Polymer Structure

  • 11.1. Braided
    • 11.1.1. Coated
    • 11.1.2. Uncoated
  • 11.2. Monofilament
    • 11.2.1. Coated
    • 11.2.2. Uncoated

12. Knotless Tissue-Closure Device Market, by Application

  • 12.1. Cardiovascular
    • 12.1.1. Valve Repair
    • 12.1.2. Vascular Anastomosis
  • 12.2. General Surgery
    • 12.2.1. Abdominal Wall Closure
    • 12.2.2. Gastrointestinal Anastomosis
    • 12.2.3. Hernia Repair
  • 12.3. Gynecologic
    • 12.3.1. Cesarean Section
    • 12.3.2. Uterine Suspension
    • 12.3.3. Vaginal Repair
  • 12.4. Ophthalmic
    • 12.4.1. Cataract Surgery
    • 12.4.2. Corneal Suturing
  • 12.5. Orthopedic
    • 12.5.1. Arthroscopic Closure
    • 12.5.2. Ligament Repair
    • 12.5.3. Tendon Repair
  • 12.6. Plastic Surgery
    • 12.6.1. Cosmetic Surgery
    • 12.6.2. Reconstructive Surgery

13. Knotless Tissue-Closure Device Market, by End User

  • 13.1. Ambulatory Surgical Centers
    • 13.1.1. Hospital Affiliated
    • 13.1.2. Standalone
  • 13.2. Clinics
    • 13.2.1. Hospital Affiliated Clinics
    • 13.2.2. Independent Clinics
  • 13.3. Hospitals
    • 13.3.1. Government
    • 13.3.2. Private
  • 13.4. Specialty Centers
    • 13.4.1. Ophthalmic Specialty Centers
    • 13.4.2. Orthopedic Specialty Centers

14. Knotless Tissue-Closure Device Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Knotless Tissue-Closure Device Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Knotless Tissue-Closure Device Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Knotless Tissue-Closure Device Market

18. China Knotless Tissue-Closure Device Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. 3M Company
  • 19.6. Angelantoni Life Science S.r.l.
  • 19.7. Angiotech Pharmaceuticals, Inc.
  • 19.8. Arctiko A/S
  • 19.9. Aucma Co., Ltd.
  • 19.10. B. Braun Melsungen AG
  • 19.11. Baxter International Inc.
  • 19.12. Blue Star Limited
  • 19.13. ConMed Corporation
  • 19.14. Dometic Group AB
  • 19.15. Evermed S.R.L.
  • 19.16. Felix Storch, Inc.
  • 19.17. Fiocchetti S.r.l.
  • 19.18. Godrej & Boyce Manufacturing Co. Ltd.
  • 19.19. Johnson & Johnson
  • 19.20. Labcold Ltd.
  • 19.21. LEC Medical
  • 19.22. Medtronic plc
  • 19.23. Migali Scientific
  • 19.24. Smith & Nephew plc
  • 19.25. So-Low Environmental Equipment Co., Inc.
  • 19.26. Standex International Corporation
  • 19.27. Stryker Corporation
  • 19.28. Teleflex Incorporated
  • 19.29. Vestfrost
  • 19.30. Zhongke Meiling Cryogenics Company Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MODE OF DELIVERY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYMER STRUCTURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS BARBED SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS BARBED SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS BARBED SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS BARBED SUTURES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS SUTURE ANCHORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS SUTURE ANCHORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS SUTURE ANCHORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SOFT TISSUE ANCHORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SOFT TISSUE ANCHORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SOFT TISSUE ANCHORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BONE ANCHORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BONE ANCHORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BONE ANCHORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS CLOSURE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS CLOSURE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS CLOSURE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS CLOSURE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SKIN CLOSURE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SKIN CLOSURE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SKIN CLOSURE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY FASCIAL CLOSURE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY FASCIAL CLOSURE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY FASCIAL CLOSURE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VASCULAR CLOSURE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VASCULAR CLOSURE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VASCULAR CLOSURE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS MESH FIXATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS MESH FIXATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS MESH FIXATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ADJUNCT TENSIONING AND FIXATION ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ADJUNCT TENSIONING AND FIXATION ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ADJUNCT TENSIONING AND FIXATION ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLIGLECAPRONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLIGLECAPRONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLIGLECAPRONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYGLACTIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYGLACTIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYGLACTIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NONABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NONABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NONABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MULTIPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MULTIPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MULTIPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SINGLE INCISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SINGLE INCISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SINGLE INCISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYMER STRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UNCOATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UNCOATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UNCOATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UNCOATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UNCOATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UNCOATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VASCULAR ANASTOMOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VASCULAR ANASTOMOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VASCULAR ANASTOMOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABDOMINAL WALL CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABDOMINAL WALL CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABDOMINAL WALL CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GASTROINTESTINAL ANASTOMOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GASTROINTESTINAL ANASTOMOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GASTROINTESTINAL ANASTOMOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HERNIA REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HERNIA REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HERNIA REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GYNECOLOGIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GYNECOLOGIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GYNECOLOGIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GYNECOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CESAREAN SECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CESAREAN SECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CESAREAN SECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UTERINE SUSPENSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UTERINE SUSPENSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY UTERINE SUSPENSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VAGINAL REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VAGINAL REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY VAGINAL REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CATARACT SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CATARACT SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CATARACT SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CORNEAL SUTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CORNEAL SUTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CORNEAL SUTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ARTHROSCOPIC CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ARTHROSCOPIC CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ARTHROSCOPIC CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LIGAMENT REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LIGAMENT REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LIGAMENT REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY TENDON REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY TENDON REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY TENDON REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PLASTIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PLASTIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PLASTIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PLASTIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COSMETIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COSMETIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY STANDALONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITAL AFFILIATED CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITAL AFFILIATED CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITAL AFFILIATED CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY INDEPENDENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY INDEPENDENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GOVERNMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 222. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 223. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS BARBED SUTURES, 2018-2032 (USD MILLION)
  • TABLE 225. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 226. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS CLOSURE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 227. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 228. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 229. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 230. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 231. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 232. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYMER STRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 233. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, 2018-2032 (USD MILLION)
  • TABLE 234. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, 2018-2032 (USD MILLION)
  • TABLE 235. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 237. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 238. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GYNECOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 239. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 240. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 241. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PLASTIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 242. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 244. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 245. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 246. AMERICAS KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS BARBED SUTURES, 2018-2032 (USD MILLION)
  • TABLE 250. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS CLOSURE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 252. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 254. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 256. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYMER STRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 258. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, 2018-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, 2018-2032 (USD MILLION)
  • TABLE 260. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 262. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GYNECOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 264. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 266. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PLASTIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 270. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 272. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS BARBED SUTURES, 2018-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS SUTURE ANCHORS, 2018-2032 (USD MILLION)
  • TABLE 276. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY KNOTLESS CLOSURE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABILITY, 2018-2032 (USD MILLION)
  • TABLE 278. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 280. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY LAPAROSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 282. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY POLYMER STRUCTURE, 2018-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY BRAIDED, 2018-2032 (USD MILLION)
  • TABLE 284. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY MONOFILAMENT, 2018-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA KNOTLESS TISSUE-CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-203